As Calls for New Treatments and Testing Methods for COVID-19 have increased Globally, Halberd Corporation (OTC: HALB) should be on Top of Everyone’s Watchlist

The US added more than 157,000 new Covid-19 cases Wednesday, according to Johns Hopkins University. The US Centers for Disease Control and Prevention urged Americans against travelling for the Thanksgiving holiday next week in light of the worsening outbreak.

Protection and prevention are viewed as key to containing and preventing the spread of the Coronavirus pandemic and re-opening the economy until a safe and effective vaccine is developed. It’s likely that the demand for testing products and services is likely to rise with the coming holiday season. For example, as travel picks up, testing and protection are likely to be key to improving confidence for passengers while potentially helping to reduce quarantine restrictions. 

As calls for new treatments and testing methods for COVID-19 have increased globally, Halberd Corporation (OTC:HALB) should be on top of everyone’s watchlist

Halberd Corp has the potential for considerable gain, whether it’s because they’re developing a treatment or their products are in greater need amid the outbreak. 

In its last press release, Halberd Corporation announced the filing of a provisional patent application on a variation of Halberd’s patented extracorporeal method to treat/eradicate Covid-19 from a patient’s blood. By using an extracorporeal (outside the body) treatment method, the patient is exposed to far fewer potential negative side effects than with more conventional treatment regimens.

Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus’. The issued patents’ extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others.

The Company’s proprietary Sequential Dialysis Technique is a methodology that physically removes the pathophysiologic basis of the disease, eliminating it without dangerous side effects.

  • Superior to current treatments which eliminate the presence of most illnesses but often with catastrophic or even fatal side effects.
  • Subtractive therapy (removal of harmful molecules) reduces risks associated with conventional “Additive” therapy (adding chemicals to the body).
  • Targets Covid-19 and similar viral diseases initially, with future efforts to develop treatments for Alzheimer’s Disease, PTSD/Traumatic Brain Injury, and cancer.

The kind of volatility and momentum seen lately in HALB shares isn’t unusual for a company who is in COVID related area. The company is a thinly traded OTC stock, meaning it is highly susceptible to volatile swings on more than average volume.

Company Highlights

Recent

The Covid-19 pandemic has brought to light a few penny stocks: (OPTI) Optec International, Inc., (LRSV) LinkResPet (ADMQ) ADM Endeavors Inc. and (SSET) Starstream...

The Covid-19 pandemic has brought the global economy to levels not seen in years, but it has also brought to light a...

As Calls for New Treatments and Testing Methods for COVID-19 have increased Globally, Halberd Corporation (OTC: HALB) should be on Top of Everyone’s Watchlist

The US added more than 157,000 new Covid-19 cases Wednesday, according to Johns Hopkins University. The US Centers for Disease Control and...

Minerco, Inc. (MINE) Stock On Watch As The Magic Mushroom Boom is Spreading Nationwide

Over the past five years, a wave of academic research has emerged which supports the notion that psychedelic-inspired medicines are effective and...

Patient Investors Can Prosper in The Long Term by initiating Positions in Solar Power-Oriented Stocks such as Solar Integrated Roofing Corporation (SIRC)

There’s a variety of appealing ways in which investors can soak up the sun. With solar powered products becoming even more affordable,...

As Joe Biden’s presidential Victory Could Lead to more Calls for Cannabis Decriminalization, American Premium Water Corp. (HIPH) is Expanding its Global Footprint

Legal cannabis has never looked more likely in the United States. Investors are clearly hopeful with a Democrat in the White House....

The pandemic isn’t likely to go away anytime soon, and that makes AllStar Health Brands Inc. (ALST) a relatively safe investment during the pandemic

There are now more than 48 million worlwide and over 9 million cases of COVID-19 confirmed in...

Joe Biden Win: A Huge Victory for the Renewable Energy Industry

For the first time ever, in April 2019, renewable energy outpaced coal by providing 23% of US power generation, compared to coal’s...

3 Sub Penny Stocks To Watch This Month: Nutra Pharma Corporation (NPHC), American Premium Water (HIPH) and American Green, Inc. (ERBB)

Nutra Pharma Corporation (OTC: NPHC) operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies...

5 Virtual Reality Stocks To Watch This Month: Himax Technologies, Inc. (HIMX), Gaensel Energy, Inc. (GEGR), Facebook Inc. (FB), Intel Corporation (INTC) and All...

Virtual reality (VR) in the gaming market was valued at USD 7.7 billion in 2019 and is projected to reach USD 42.50...

2 Therapeutic Stocks To Watch This Month: Frequency Therapeutics, Inc. (FREQ) and Electromedical Technologies, Inc. (EMED)

Physical therapy continues to be a growing field with a positive outlook as a career path. It is a $30 billion industry with...

4 Cannabis Stocks To Watch This Month: TransAtlantic Capital Inc. , CV Sciences, Inc., Canopy Growth Corporation and Aurora Cannabis Inc.

The growth in cannabis sales appears to have brought some relief to cannabis stocks, which have been going through a rough period....

The Coronavirus isn’t Stopping Splash Beverage Group, Inc. (SBEV) from Growing

Global Rehydration drink sales reached a value of $53.01 billion in 2018 and are expected to grow at a CAGR of 7.20%...

3 Healthcare Stocks Weathering The Coronavirus Storm Right Now: Progressive Care, Inc. (RXMD), Moderna, Inc. (MRNA) and Gilead Sciences (GILD)

The biotech industry is expected to balloon to a massive $727B in the next five years. And along the way, we’ll also see new...